Jo Haviland

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

E. Sawyer, J. Yarnold, C. Coles, 2020, The Lancet.